COCP Surge: Cocrystal Pharma Climbs 4.4% to $0.95 in 24-Hour Trading
COCP stock jumps 4.4% to $0.95, up from $0.76 last month, as biotech Cocrystal Pharma pushes antiviral research toward hepatitis, influenza, and norovirus breakthroughs.
- COCRYSTAL PHARMA INC
- United States
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- AI generated
2 minutes to read